Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated rewardPHARMACOLOGICAL RESEARCHIF10.52022-11-019OAAI
Inhibition of PSD95-nNOS protein-protein interactions decreases morphine reward and relapse vulnerability in ratsADDICTION BIOLOGYIF2.62022-08-118OAAI
The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesiasNEUROBIOLOGY OF DISEASEIF5.62021-11-0110OAAI
The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependenceEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72020-11-0137OAAI
Cannabinoid CB2Receptor Activation Attenuates Fentanyl-Induced Respiratory DepressionCANNABIS AND CANNABINOID RESEARCHIF2.72020-10-2114OAAI
Positive Allosteric Modulation of CB1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or RewardFRONTIERS IN MOLECULAR NEUROSCIENCEIF3.82020-04-2854OAAI
Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian ratsNPJ PARKINSONS DISEASEIF8.22019-11-299OAAI
Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal TransitJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82018-12-0130OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向